VCM
CELG

Versant Capital Management’s Celgene Corp CELG Stock Holding History

Versant Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-336
Closed -$33K – 1746
2019
Q3 		$33K Buy
336
+29
+9% +$2.76K 0.02% 306
2019
Q2 		$28K Sell
307
-266
-46% -$25.3K 0.01% 365
2019
Q1 		$54K Buy
573
+39
+7% +$3.41K 0.02% 255
2018
Q4 		$34K Hold
534
– – 0.02% 350
2018
Q3 		$47K Hold
534
– – 0.02% 311
2018
Q2 		$42K Sell
534
-14
-3% -$1.16K 0.02% 352
2018
Q1 		$48K Buy
548
+1
+0.2% +$96 0.02% 303
2017
Q4 		$57K Buy
547
+29
+6% +$3.27K 0.02% 276
2017
Q3 		$75K Sell
518
-274
-35% -$37.3K 0.04% 181
2017
Q2 		$102K Sell
792
-86
-10% -$10.5K 0.06% 132
2017
Q1 		$109K Sell
878
-27
-3% -$3.23K 0.06% 122
2016
Q4 		$104K Sell
905
-123
-12% -$13.7K 0.06% 127
2016
Q3 		$107K Buy
1,028
+5
+0.5% +$541 0.06% 125
2016
Q2 		$100K Sell
1,023
-39
-4% -$4.03K 0.06% 128
2016
Q1 		$106K Sell
1,062
-30
-3% -$3.09K 0.06% 119
2015
Q4 		$130K Buy
+1,092
New +$126K 0.08% 97

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Versant Capital Management's CELG Position: Q4 2019 in Review

Versant Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 336 shares — an estimated $33K sold.

Versant Capital Management first reported a position in CELG in Q4 2015 and held it in 16 quarters. The position peaked at $130K in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Versant Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Versant Capital Management sold 336 Celgene Corp shares in Q4 2019, an estimated $33K.
  • Versant Capital Management first reported a position in Celgene Corp in Q4 2015 and held it in 16 quarters.
  • Versant Capital Management's Celgene Corp position peaked at $130K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Versant Capital Management's 13F filing for Q4 2019, filed 28 Jan 2020.